This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
119 posters, 6 topics, 524 authors, 243 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
29-30 June, 2026 | QEII Centre, Westminster

66
Lin Ling Xu , William Verrier, Kumaresh Skanthabalan, Madhavi Venumbaka
AI vigilance – Post-implementation monitoring, real world performance evaluation, health economic evaluation
East Suffolk and North Essex NHS Foundation Trust
2nd Annual Global AI Conference 2024
Dr. L Xu, W. Verrier, Dr. K Skanthabalan, Dr. M Venumbaka
East Suffolk and North Essex NHS Foundation Trust
Gleamer BoneView is an AI-powered software designed to assist clinicians in interpreting trauma musculoskeletal (MSK) radiography specifically for the detection of fractures, dislocations, effusions and lesions across various anatomical regions³. The software has been in use at our district general hospital (DGH) since June 2024. Literature suggests that BoneView can:
In this audit, we aimed to measure the sensitivity and specificity of the Gleamer BoneView software in detecting MSK abnormalities on radiographs. These results helped inform us of the clinical impact of BoneView errors.
n = 82
The sample size was determined using an appropriate calculator⁴ for a single-test design, assuming an expected AI sensitivity of 92%⁵ and a disease prevalence of 30%⁶,⁷. This sample size ensures sufficient statistical power to reliably evaluate AI performance, meaning the study is adequately powered to demonstrate statistically significant results for fracture detection. The assumptions used allow for precise estimation of sensitivity and specificity within an acceptable confidence interval.
377 cases were assessed with a total of 109 fractures (28.9%). BoneView showed a sensitivity of 92.6% and specificity of 91.4% for fracture detection; of these, 9 false negatives and 22 false positives were identified (fig.1). The ones identified within discrepant cases (false positives and false negatives) included presence of old fractures, ossicles, growth plates and artefact or metallic prosthesis (fig 2,3). Only one discrepant case (false positive i.e. overcall) was deemed clinically significant as it led to unnecessary further imaging (fig 2A). The only other clinically significant BoneView error was of one missed dislocation.
Prevalence of effusion (10.1%), lesion (1.6%) and dislocation (4.3%) were too low to enable any meaningful statistical analysis on BoneView's ability to detect these pathologies.
Fig. 1. Contingency Table
| Fracture Present | Fracture Absent | |
|---|---|---|
| BoneView Result Positive | True Positive = 100 | False Positive = 22 |
| BoneView Result Negative | False Negative = 9 | True Negative = 246 |
N = 377
Sensitivity: 92.6%
Specificity: 91.4%
Fig. 2. False positive (an under-called case for a landmark fracture (A). This error is non-significant since it was picked up on post-manipulation imaging. Shoulder dislocation was correctly identified (B).
Fig. 3. False positive cases. Case A was a significant error as this resulted in a CT that was not required. Other common false positives included growth plates (B) and user hardware (C).
BoneView showed a high sensitivity and specificity for fracture detection which was expected, and interestingly better than reported in some previous studies⁷. Overall, it has proven to have a very low rate of significant clinical error.
This work supports the notion that AI is a useful software adjunct for reporters to optimise detection of MSK abnormalities and boost workflow.